Growth Hormone in Narcotic Addiction
The DOI matches its Crossref record.
Abstract
Growth hormone (GH) levels were measured in normals, methadone-treated, former heroin addicts and actively addicted male patients during and after insulin hypoglycemia. Normal GH response to adequate hypoglycemia was observed in the controls and the abstinent former addicts. Although most heroin-addicted and methadone maintained patients also responded normally, some in each category had suboptimal responses. Some of these GH hyporesponders also had subnormal cortisol responses to hypoglycemia. Serum LH, T-4, T-3 and PBI's usually were normal in both heroin addicted and methadone maintained patients regardless of the magnitude of their GH responses. There was no correlation of GH responsiveness with duration of addiction, daily average cost of addiction, dose of methadone or duration of methadone maintenance. There were no clinical stigmata of hypopituitarism in any patient. The evidence suggests a mild subtle hypothalamic-pituitary dysfunction may be present in some patients characterized principally by subnormal GH and cortisol responses to insulin hypoglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mean of peak GH was similar in all groups.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [138]
In the citing paper
“However, 26% of the methadonetreated group and 31% of the heroin-addicted people exhibited abnormal GH peak on the ITT (138).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [138]
Citations
Cited by
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
Naeye, R. L., Blanc, W., Leblanc, W., & Khatamee, M. A. (1973) · The Journal of Pediatrics · doi:10.1016/s0022-3476(73)80550-5 · Cited by 190
MEDICAL COMPLICATIONS IN METHADONE PATIENTS*
Kreek, M. J. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb16769.x · Cited by 140
Decreased serum testosterone concentration in male heroin and methadone addicts
Azizi, F., Vagenakis, A. G., Longcope, C., Ingbar, S. H., & Braverman, L. E. (1973) · Steroids · doi:10.1016/0039-128x(73)90002-0 · Cited by 130
THE EFFECT OF HEROIN ADDICTION ON PITUITARY‐TESTICULAR FUNCTION
WANG, C., CHAN, V., & YEUNG, R. T. T. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb03585.x · Cited by 109
Metadata
- Authors
- CUSHMAN, P.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- Corresponding author
- CUSHMAN, PAUL
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1972-09
- Volume
- 35
- Issue
- 3
- Pages
- 352-358
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2039584024
- Semantic Scholar
- 39da246d5ef813c56c14704a0013689328266ec4
- Cited by
- 41
- References
- 0
- Citations by year
- 2024: 1 · 2022: 1 · 2019: 1 · 2018: 1 · 2014: 2 · 2013: 2
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- growth hormone, drug addiction, heroin addiction, methadone maintenance treatment, insulin-induced hypoglycemia, cortisol response, hypothalamic-pituitary dysfunction, pituitary function, thyroid hormones, luteinizing hormone
- MeSH terms
- Adult, Blood Glucose, Heroin, Fatty Acids, Nonesterified, Glucose Tolerance Test, Humans, Hydrocortisone, Hypoglycemia, Hypothalamo-Hypophyseal System, Insulin, Luteinizing Hormone, Male, Methadone, Growth Hormone, Thyroxine, Triiodothyronine, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth Hormone in Narcotic Addiction. https://app.cochat.ai/papers/10.1210/jcem-35-3-352
- The paper
- CUSHMAN, P. (1972). Growth Hormone in Narcotic Addiction. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-35-3-352
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.